Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ROCKET PHARMACEUTICALS, INC. has filed 937 SEC EDGAR filings since 25 Feb 2004

SEC filing history

Showing 726-750 of 934 matching filings.

Per page
25
Current page
30
8-K File 001-36829

8-K

Filing date
07 Jul 2017
Reporting date
07 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36829

FORM 8-K

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36829

FORM 8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36829

DEF 14A

Filing date
26 Apr 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36829

FORM 8-K

Filing date
13 Apr 2017
Reporting date
11 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216892

S-8

Filing date
23 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36829

FORM 8-K

Filing date
16 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

SC 13G/A

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

SCHEDULE 13G/A, AMENDMENT #2

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88750

13G

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88750

SC 13D/A

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

SC 13G/A filing

Filing date
08 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

SC 13G/A filing

Filing date
07 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

13G AMENDED ANNUAL FILING (ITEK)

Filing date
03 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .